Ozempic (semaglutide) injection is a once-weekly medication in the GLP-1 receptor agonist class of drugs. It is used in adults with type 2 diabetes, along with healthy eating and physical activity, to improve glucose. It comes in 0.5 mg, 1 mg, or 2 mg doses.
Ozempic helps to release insulin and lowers the amount of glucose produced by the liver when glucose rises at mealtime. It also slows the absorption of mealtime glucose.
For adults with type 2 diabetes and known heart disease, Ozempic is used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death.
For adults with type 2 diabetes and chronic kidney disease, Ozempic is used to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death.
- Helps manage blood glucose in adults with type 2 diabetes, not suitable for people with type 1 diabetes.
- Use can result in weight loss. Semaglutide is separately approved under the brand name Wegovy to treat obesity.
- Promotes weight loss by slowing gastric emptying and increasing satiety, though not FDA-approved solely for weight management.
- Reduces cardiovascular and kidney risk in people with heart and kidney disease.
Ozempic Specs
Key specification
General Information
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
